Higher physical activity (PA) is associated with lower heart failure (HF) risk; however, the effect of changes in PA on HF risk is unknown.
H
igher levels of physical activity (PA) and physical fitness are strong predictors of overall good heath and lower mortality. [1] [2] [3] Physically active individuals are less likely to suffer from chronic conditions such as hypertension, diabetes mellitus, depression, and cancer. [4] [5] [6] [7] In addition to the beneficial effects on several cardiovascular risk factors, PA is also associated with a lower risk of cardiovascular events, including heart failure (HF). 8, 9 PA has a graded inverse relationship with incident HF, with individuals with the highest levels of PA having the lowest risk of HF. 8 However, despite the widely recognized beneficial effects of PA, <50% of the US population meets recommended levels of exercise. 10 With the rising prevalence of HF in the population, 11 prevention of HF is an urgent clinical and public health mandate. Given the high levels of physical inactivity in the community, national organizations emphasize the cardiovascular benefits of increasing exercise activity in the general population. 12, 13 Increases in PA over time are associated with lower risks of coronary heart disease (CHD) and total mortality, [14] [15] [16] but there are limited data regarding the effects of changes in PA over time on HF risk. 17 Similarly, although several studies demonstrate benefits from exercise training programs among individuals with HF, 18 no similar studies have been conducted assessing the potential benefits of exercise training for HF prevention. If changes in PA over time have a significant association with the risk for developing HF, this finding could have important clinical implications for HF prevention strategies.
Therefore, we evaluated the association between 6-year changes in PA and HF risk within the prospective, community-based ARIC study. With serial assessments of PA at study visits and extended active surveillance for HF events, ARIC provides an excellent opportunity for examining this association. We additionally assessed whether the association between PA change and HF risk differs across age, race, and sex subgroups.
METHODS
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure. However, the ARIC study data are publicly available through the database of Genotypes and Phenotypes and the National Heart, Lung, and Blood Institute Biological Specimen and Data Repository Information Coordinating Center. 19 
Study Site and Participants
The ARIC study is a prospective cohort of predominantly black and white participants designed to evaluate the risk factors for cardiovascular disease (CVD). A total of 15 792 individuals between 45 and 64 years of age were recruited from 4 US population centers between 1987 and 1989: Forsyth County, NC; Jackson, MI; suburbs of Minneapolis, MN; and Washington County, MD. After the baseline examination, 3 subsequent study visits were conducted at 3-year intervals: visit 2 (1990-1992) , visit 3 (1993-1995) , and visit 4 (1996-1998) . A fifth visit occurred between 2011 and 2013. Cohort participants have been followed continuously for CVD events through annual telephone interviews and examinations of death certificates and hospitalization records. Further details regarding the study design have been previously described. 20 For this analysis, we included 11 351 participants who attended visit 3, excluding the limited number of participants not of black or white race (n= 38); the small number of black participants from the Minnesota and Washington County centers (n=42); those with baseline CHD or HF (n=1380) defined as self-reported CHD or HF at visit 1; adjudicated CHD event at or before visit 3, including fatal/nonfatal myocardial infarction (MI), silent MI, coronary revascularization, HF hospitalization, or death at or before visit 3; and those missing PA data at visits 1 and 3 (n= 62) or information on covariates in the primary regression model (n=14). All participants provided informed consent, and the institutional review boards associated with all ARIC study centers approved the study protocol.
PA and Covariates
PA in ARIC was assessed using a modified intervieweradministered Baecke Questionnaire at visits 1 (1987-1989 ) and 3 (1993-1995) , which were separated by a 6-year interval. Participants itemized leisure time exercise activities and
Clinical Perspective
What Is New?
• Although studies have reported that higher physical activity (PA) levels are associated with lower heart failure (HF) risk, there are limited data on the effect of starting or increasing PA over time on HF risk.
• In the present study, we demonstrate that although persons who maintain levels of PA recommended by the American Heart Association over time have the lowest HF risk, increasing PA over a 6-year interval is also associated with reduced HF risk, whereas decreasing PA over the same time period is linked to higher HF risk.
• Also, the initiation of activity among those who were previously sedentary is associated with lower HF risk.
What Are the Clinical Implications?
• Our findings support the importance of effective interventions to promote engagement in PA as a strategy for HF prevention in the general population.
• Furthermore, it suggests clinical benefits in association with the initiation of regular PA among sedentary individuals, even in late middle age.
• Given the high proportion of individuals with suboptimal levels of PA and the increasing prevalence of HF, population-based strategies to promote and maintain higher levels of PA could have an important public health impact. 
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answered questions regarding the frequency of participation in each, detailing the number of hours per week and months per year performing each activity. The reliability and validity of this questionnaire overall and among males and females were previously reported. [21] [22] [23] As was done for prior ARIC analyses, 24 for the present study, each activity was converted into a MET based on its intensity, as per the Compendium of Physical Activities. Moderate exercises were defined as those involving a workload of 3 to 6 METS and vigorous exercises as those involving a workload of >6 METS. Using the duration of PA per week and number of months per year, a continuous variable of MET*minutes/week was generated. PA levels were subsequently categorized as per current American Heart Association recommendations 25 as: recommended (≥75 minutes/week of vigorous intensity or ≥150 minutes/week of any combination of moderate+vigorous intensity exercise), intermediate minutes/week of vigorous intensity or 1-149 minutes/week of any combination of moderate+vigorous intensity exercise), or poor (0 minutes/week of moderate or vigorous exercise).
Covariates of interest were assessed at visits 1 and 3. Information on demographics and clinical comorbidities were obtained using an interviewer-administered questionnaire and physical examination. Laboratory data were obtained from blood samples collected at each visit. Smoking status was categorized as current or nonsmoker. Alcohol consumption was measured in grams per week. Body mass index (BMI) was calculated based on height and weight and reported in kg/m 2 . Systolic blood pressure was reported as the average of the last 2 of 3 measurements from the same examination. Diabetes mellitus was defined according to fasting or nonfasting blood sugar measurements ≥126 mg/dL or ≥200 mg/dL, respectively, a self-reported physician diagnosis of diabetes mellitus, or the use of hypoglycemic medications. Total cholesterol, high-density lipoprotein cholesterol, and triglycerides were measured with enzymatic assays.
Primary Outcome
The primary outcome was incident HF, defined as the first hospitalization or death related to HF occurring after visit 3 (baseline) until December 31, 2013. Hospitalized HF was determined from hospital discharge codes and HF deaths from the underlying cause assigned on the death certificate. International Classification of Diseases-9 code 428 was used to determine HF hospitalizations and deaths in early follow-up, and International Classification of Diseases-10 code I-50 was used to identify HF deaths in later follow-up. Hospital discharge documentation and death certificates with HF codes at any position were used for incident HF diagnosis for the main analyses. We conducted additional sensitivity analyses only considering hospitalizations where HF was the primary diagnosis.
Secondary Outcomes
We performed secondary analyses using biomarkers of subclinical myocardial damage (high-sensitivity cardiac troponin Tr [hs-cTnT]) and wall stress (N-terminal of the prohormone of brain natriuretic peptide [NT-proBNP]), measured at ARIC visit 4, as the outcomes of interest. Hs-cTnT and NT-proBNP were measured in 2011 from plasma samples collected at visit 4 using a sandwich immunoassay method on the on the Roche Elecsys 2010 Analyzer (Roche Diagnostics Corporation). Elevated hs-cTnT was defined as a level ≥14 ng/L, a cut point that has been associated with significantly increased HF risk in prior analyses. 26, 27 Elevated NT-proBNP was defined as >100 pg/mL, a level previously associated with HF.
28,29

Statistical Analyses
We performed bivariate comparisons of participant characteristics at visit 3 across the categories of PA: poor, intermediate, and recommended. The χ 2 test was used for comparison of categorical variables and ANOVA for continuous variables. Also, to assess how clinical comorbidities were associated with changes in PA level, we compared the baseline characteristics of persons who increased and those who decreased their PA category over time.
We constructed adjusted Cox proportional hazards models to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for incident HF associated with changes in PA performance over the 6 years from visit 1 to visit 3. In our main model, we adjusted for possible confounders such as age, sex, race, smoking status, and alcohol intake measured at baseline (visit 3). We performed additional analyses further adjusted for variables potentially on the causal pathway between PA and incident HF to test whether the association might be explained by levels of systolic blood pressure, use of antihypertensive medications, diabetes mellitus, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, and BMI. Model 2 included the variables above measured at visit 1. Model 3 included both model 2 variables and the variables measured at visit 3 to account for changes in these CVD risk factors over time.
We constructed Kaplan-Meier graphs and used the logrank test to assess differences in the HF-free survival between those who increased their PA category from visits 1 to 3 versus those with stable low activity over time (stable PA category and below the median average activity across visits 1 and 3) and between those who decreased their PA category from visits 1 to 3 versus those with stable high activity (stable PA category and greater than or equal to the median average activity across visits 1 and 3). We additionally used multivariable adjusted Cox proportional hazards models to compare the HF risk associated with increasing versus stable low PA category and with decreasing versus stable high PA category. We performed these analyses in the overall study population and stratified by obesity status (BMI <30 and ≥30 kg/m 2 ), with tests for interaction to assess whether these associations differed for individuals with and without excess weight. We also evaluated the changes in BMI from visits 1 to 3 among those with stable high PA, stable low PA, increases in PA category, and decreases in PA category using ANOVA to perform comparisons across groups.
To further evaluate the HF risk associated with changes in PA categories over time, we created cross-categories of PA at visits 1 and 3. We calculated adjusted incidence rates and associated 95% CIs for HF within each cross-category of PA using Poisson regression. Also, using those with poor PA levels at both visits 1 and 3 as the reference group, we estimated the HRs and 95% CIs for incident HF associated with each of the other cross-categories of PA at visits 1 and 3. In sensitivity analysis, we created cross-tertiles of PA at both visits and performed similar analyses. We performed the regression analyses described earlier stratified by age, sex, and race and tested for interactions with these demographic variables on the outcome of incident HF. We performed sensitivity analyses considering only hospitalizations with HF as the primary discharge diagnosis. To account for the possibility of subclinical HF affecting PA levels, we conducted additional sensitivity analyses evaluating the association of cross-categories of PA and incident HF after excluding incident HF cases that occurred in the first 5 years during follow up. We performed additional regression analyses including both visits 1 and 3 activity in the same regression model to learn whether they both contributed individual prognostic information when PA at both time points were simultaneously taken into account.
To assess the implications of increasing activity over time among those with poor activity at baseline, we evaluated the HF risk associated with increasing PA in this subgroup, modeling PA increase from visits 1 to 3 as 1 SD higher increase (512 MET*minutes/week) and as tertiles of increasing activity. We also evaluated the decreases in HF risk associated with each 750 and 1000 MET*minutes/week increase in PA among those who were previously sedentary. We additionally constructed restricted cubic spline models to characterize the continuous association of increases in PA levels from visits 1 to 3 with incident HF among individuals with zero, moderate or vigorous PA at visit 1.
We evaluated the association of cross-categories of PA at visits 1 and 3 with elevated hs-cTnT and NT-proBNP to assess the relationship of PA change with these biomarkers of subclinical myocardial abnormalities.
Statistical analyses were performed with Stata version 13.1. All P values presented are 2-sided.
RESULTS
Among the 11 351 ARIC participants included in the present study, the mean age was 60 years, and 57% were women. Approximately 42% of the study population performed recommended levels of PA at visit 3, whereas 23% performed intermediate activity and 35% had poor activity levels (Table 1) . Individuals with recommended levels of PA were less frequently black or female, had lower mean BMI and systolic blood pressure, were less likely to use antihypertensive medications, have diabetes mellitus and be smokers, and had higher mean high-density lipoprotein cholesterol.
Between visits 1 and 3, PA category increased in 24% of the participants, decreased in 22%, and remained stable in 54%. Only 26% of the study population had recommended levels of PA at both study visits (Figure 1) . Also, 35% of participants who performed recommended levels at visit 1 decreased their activity level by visit 3. Twenty percent of the study population performed no moderate or vigorous PA at both study visits, and among those who had poor activity at visit 1, only 20% increased to recommended levels of activity at visit 3. Participants who increased their PA were slightly older, were more likely to be black, were less likely to be current smokers, and had lower BMI compared with those who decreased PA over time (Table I in the online-only Data Supplement).
Over a median follow-up time of 19 years, 1750 HF events occurred, including 1693 hospitalizations and 57 deaths because of HF. As shown in the Kaplan-Meier curves in Figure 2 , those individuals with stable high PA from visits 1 to 3 had the greatest cumulative HF-free survival, whereas those with stable low PA from visits 1 to 3 had the lowest cumulative HF-free survival. Persons who increased their PA category from visits 1 to 3 had a significantly higher HF-free survival than those with Values are %, n (%), or mean (SD).
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stable low PA (P from log-rank test =0.049). In addition, persons who decreased their PA category from visits 1 to 3 had a lower HF-free survival than those with stable high PA (P from log-rank test =0.002).
We found analogous results in multivariate regression analyses. The risk of incident HF was significantly lower in those who increased their PA category from visits 1 to 3, compared with those with stable low PA (HR, 0.88; 95% CI, 0.78-1.00). Conversely, a decrease in PA category over time compared to stable high PA was associated with an HR for incident HF of 1.18 (95% CI, 1.02-1.36).
We examined changes in BMI in association with stable high, stable low, increasing, and decreasing PA category (Table II in the online-only Data Supplement). Although each group increased in BMI over time, we saw significant differences in the amount of BMI increase across groups (P for comparison across groups using ANOVA <0.001). The greatest mean increase in BMI was seen for those who decreased in PA category over time (≈1.2 kg/m 2 ), followed by those stable low PA (≈1 kg/m 2 ) and then by those with stable high and increasing PA category over time (both ≈0.8 kg/m 2 ). In stratified analyses, we found trends toward increased HF risk in association with a decrease in PA category and decreased HF risk in association with an increase in PA category among individuals with and without obesity (Table III in When examining cross-categories of PA at visits 1 and 3, we found the lowest HF incidence rate for those with persistently recommended activity (7.1 events per 1000 person-years) and the highest HF incidence rate among with persistently poor activity (10.2 events per 1000 person-years; Table 2 ). Also, within each level of PA at visit 1, a higher PA category at visit 3 was associated with lower incident HF rates.
In Cox regression models adjusted for confounders examining cross-categories of PA at visits 1 and 3 (model 1; Table 3 ), with those with persistently poor PA as the reference group, individuals with recommended activity levels at both visits had the lowest HF risk (HR, 0.69; 95% CI, 0.60-0.80). Significantly lower HF risk was also present for those who engaged in no less than intermediate activity at both time points. It is important to note that those individuals who increased their level of PA from poor to recommended also had a significantly lower risk of incident HF (HR, 0.77; 95% CI, 0.63-0.93).
In regression analyses additionally adjusted for variables potentially on the causal pathway between PA and incident HF (systolic blood pressure, antihypertensive medications, diabetes mellitus, and BMI), measured Kaplan-Meier estimates of HF-free survival among participants with stable PA category at visits 1 and 3 that was below (stable low) or equal to or above (stable high) the average median levels of PA at both visits; those who decreased their PA category from visits 1 to 3 (from recommended to intermediate or poor activity or from intermediate to poor activity); and those who increased their PA category from visits 1 to 3 (from poor to intermediate or recommended activity or from intermediate to recommended activity). P from log-rank test comparing those who increased PA category to persons with stable PA below the median =0.049. P from log-rank test comparing those who decreased PA category to persons with stable PA above the median =0.002. HF indicates heart failure; and PA, physical activity. ORIGINAL RESEARCH ARTICLE at visit 1 (model 2) and at both visits 1 and 3 (model 3), patterns were similar, although findings were attenuated. However, statistically significant associations with lower HF risk remained for persons with persistently recommended activity as well as for those who increased from poor to recommended levels of activity.
We found similar results across age (<65 years or ≥65 years), race, and sex subgroups, without evidence of statistically significant interactions between PA change and these demographic variables on the incident HF outcome. Analogous findings were seen when PA at each time point was modeled as tertiles (Table  IV in the online-only Data Supplement), after excluding incident HF events during the first 5 years of followup (Table V in the online-only Data Supplement), and when only including hospitalizations where HF was the primary discharge diagnosis (Table VI in the online-only Data Supplement).
When PA at both time points were simultaneously included in our regression model, recommended levels of PA at each study visit were associated with a significantly lower risk of HF (HR, 0.84; 95% CI, 0.74-0.95 and HR, 0.80; 95% CI, 0.71-0.90 for visits 1 and 3, respectively). Similar analysis, with PA modeled continuously per 1 SD, confirmed that higher PA at visit 1 (P=0.013) and visit 3 (P=0.001) were both associated with lower HF risk.
In analyses restricted to those reporting no exercise PA at visit 1 (n = 3920), higher tertiles of PA increase over time in this subgroup were associated with decreased HF risk (Table VII in the online-only Data Supplement), with those in the highest versus the lowest tertile of PA increase having an HR of 0.66 (95% CI, 0.52-0.84). In restricted cubic spline models among participants reporting no PA at visit 1, there was a graded, approximately linear association between greater increases in PA and decreasing risk of HF (Figure 3) . We found that each 1-SD increase in PA by visit 3 (SD: 512.5 MET*minutes/week) was associated with an HR of 0.89 (95% CI, 0.82-0.96) for the risk of incident HF. Also, a dose-response association was seen, with greater increases in activity associated with less HF risk: each 750 MET*minutes/week increase in PA was associated with an HR of 0.84 (95% CI, 0.75-0.95) for HF and each 1000 MET*minutes/ week increase in PA was linked to a HR of 0.79 (95% CI, 0.68-0.93).
Additional analyses evaluating the association between PA change from visits 1 to 3 and elevated hscTnT demonstrated similar results (Table VIII in 
Those with persistently poor levels of physical activity were used as a common reference. *Adjusted for age, race, sex, smoking status, and alcohol use measured at visit 3. †Adjusted for the variables in Model 1 + systolic blood pressure, use of antihypertensive medications, diabetes mellitus, low-density lipoprotein cholesterol, highdensity lipoprotein cholesterol, triglycerides, and body mass index measured at visit 1.
‡Adjusted for the variables in Model 2 + systolic blood pressure, use of antihypertensive medications, diabetes mellitus, low-density lipoprotein cholesterol, highdensity lipoprotein cholesterol, triglycerides, and body mass index measured at visit 3. 
CI, 0.59-1.10). In contrast, no statistically significant associations were seen between cross-categories of PA and elevated NT-proBNP (OR, 0.95; 95% CI, 0.83-1.09 for persons with persistently recommended levels of PA; Table VIII in the online-only Data Supplement).
DISCUSSION
In this prospective, biracial cohort of middle-age adults, we found that changes in PA over 6 years were significantly associated with HF risk over the next 2 decades. Individuals with any increase in PA category experienced significantly lower risk, whereas those with any decrease in PA category had an increased HF risk. Although those who performed recommended levels of PA at both visits 1 and 3 had the lowest HF risk, an increase from poor to recommended activity was also associated with a lower risk of incident HF. Among individuals reporting no PA at visit 1, each 512.5 MET*minutes/week (1 SD) higher level of PA at visit 3, corresponding to ≈30 minutes of brisk walking 4 times a week, was associated with a 11% lower risk of HF. Also, greater levels of PA increase over time were associated with lower HF risk: each 1000 MET×minute/ week increase in PA, corresponding to biking for leisure (moderate effort) for ≈30 minutes 4 times a week, was linked to a 21% lower risk of HF. These findings indicate that increasing and even initiating exercise PA in late middle age is associated with reduced HF risk in the general population. Furthermore, more substantial increases in PA among those who are initially sedentary may be linked to lower HF risk.
Data from the American Heart Association suggests that <50% of the US population performs adequate levels of PA. 10 The present study provides additional longitudinal information, showing that although 39% and 42% of the study participants performed recommended levels at visits 1 and 3, respectively, only 25% of the study population reported consistently recommended levels of PA over the 6-year follow-up study period.
The present study adds to a body of literature indicating that changes in PA levels over time are important predictors of cardiovascular outcomes, including incident CHD, CVD death, and all-cause mortality. 15, 30 Several prior cohort studies, including the ARIC study, FHS (Framingham Heart Study), CHS (Cardiovascular Health Study), WHI study (Woman's Health Initiative), MESA (Multi-Ethnic Study of Atherosclerosis), and others, have demonstrated a graded association between higher levels of baseline PA and lower risk of incident HF. 8, 31 However, there are limited prior data regarding the prospective association of changes in exercise PA levels over time with HF risk.
The mechanisms by which changes in PA are associated with HF risk are not well understood. Increasing levels of PA are associated with improved metabolic profiles, including decreases in fasting glucose and BMI and increases in high-density lipoprotein cholesterol. 32 Exercise training is associated with lower blood pressure among individuals with normal blood pressure and those with hypertension. 33 However, even after adjustment for measures of risk factors potentially on the causal pathway between PA and HF, including BMI and other variables at both time points, we continued to find significant associations between PA change and HF risk. This finding suggests that the protective effects of PA change against HF are at least partially independent of traditional risk factors. The additional finding that cross-categories of PA are associated with subclinical myocardial damage may have some implications for the mechanisms underlying this association.
34-36 Although we did not have the data available to explore associations of PA change with incident HF with preserved and reduced ejection fraction in this analysis, a growing body of data suggests that the protective associations of PA with incident HF may be stronger for HF with preserved ejection fraction than HF with reduced ejection fraction. 31, 37 Past studies have also demonstrated associations between higher levels of fitness and decreased HF risk. 3, 38 In a recent study, improvements in midlife fitness (determined by a maximal treadmill exercise test) over a mean 4-year period were significantly associated with a lower risk of incident HF. 39 However, in terms of preventive strategies, although it is feasible to counsel individuals on performance of PA, one cannot prescribe an improvement in fitness. Furthermore, although fitness levels correlate with levels of regular PA, many other nonmod- ifiable factors also influence an individual's cardiorespiratory fitness level, such as age, sex, race, body composition, and genetic makeup. 40 Therefore, the information provided by this analysis regarding the HF risk associated with simple changes in PA levels over time may be directly relevant to recommendations in clinical practice and prevention campaigns in the general community.
As the prevalence of HF increases with the aging population and increased survival from CHD events, and given the high morbidity and mortality associated with HF, defining strategies to prevent future HF has become increasingly important. Observational data suggest that adherence to a healthy lifestyle that includes regular participation in PA is associated with a 40% to 80% reduction in the risk of HF. [41] [42] [43] Our study adds to these data, indicating that initiating recommended PA in midlife is associated with >20% lower risk of HF, and decreasing participation in PA is associated with adverse consequences. The study further emphasizes the importance of assessing and promoting participation in PA at routine ambulatory encounters as an important component of preventive efforts. 44 Also, given the high proportion of participants with suboptimal levels of PA at any time, population-based strategies to promote and maintain higher levels of PA could have an important public health impact and could be a highly cost-effective strategy for preventing HF. 45 Strategies targeting blacks and women may be of particular utility because these groups were significantly less likely to achieve recommended PA in the present study.
Several unanswered questions remain, including whether certain types of exercise or exercise regimens (short bursts of high-intensity versus endurance training or even just low-intensity walking) are better than others for HF risk reduction and for exactly how long one needs to engage in regular PA to derive any benefit. Although further work is needed to define optimal exercise recommendations, this analysis indicates that initiating regular exercise in many forms likely has tangible benefits for reducing HF risk.
This analysis has certain limitations. PA was self-reported rather than objectively measured, and therefore it is associated with reporting and measurement error. It is possible that some of the observed changes in reported PA are because of regression to mean, although the significant risk associations observed support the biological relevance of the described PA changes. Also, although changes in activity were assessed over 6 years, it is possible that unmeasured changes in activity during that interval may have additionally influenced HF outcomes. This analysis only accounted for sports and did not include work-related or commuting PA. Furthermore, as with all observational studies, we cannot exclude the possibility of residual confounding because unrecognized factors may differ between those who chose to exercise and those who did not.
Although the use of International Classification of Diseases codes for HF diagnosis is subject to misclassification, our findings are consistent with a recently published study using the same ascertainment strategy showing that higher average levels of PA and increases later in life were associated with more favorable echocardiographic parameters of left ventricular function. 46 This analysis also doesn't include data on PA levels or clinical characteristics after visit 3. Similarly, although we cannot exclude the possibility that decreases in PA over time were related to clinical comorbidities, most baseline characteristics did not differ significantly between those who decreased and those who increased PA. Furthermore, our findings were consistent in multiple sensitivity analyses using clinical and subclinical outcomes and after excluding HF cases during the first 5 years of follow-up. Nonetheless, by using serial measurements of PA in a large, biracial, community-based cohort of middle-age individuals with long-term follow-up for HF events, this analysis provides important insights regarding the association between PA changes and HF risk that are broadly generalizable.
In summary, in this analysis of a community-based population sample free of baseline CVD, increasing PA over 6 years was associated with reduced HF risk over the next 2 decades, whereas decreasing activity over time was associated with greater HF risk. Furthermore, although the lowest HF risk was seen among those with persistently recommended PA, increasing from poor to recommended activity levels over 6 years was also associated with significantly decreased HF risk. Although a clinical trial would be needed to prove it, these findings suggest that initiating and augmenting PA in middle age may be an important component of strategies to prevent HF.
